CAR T Cell Therapy in MDS/AML

This webinar will provide an overview on CAR T cell immunotherapy, an approach that takes patients’ own immune cells and equips them with chimeric antigen receptors (CARs) that enhance their ability to target and eliminate cancer cells. Recent advances leading to next-generation CAR T therapies for MDS/AML patients will be discussed.